44
Growth Score in past quarter
pts
Heat Score 44 in past quarter
-22 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
471351
EmbarkNeuro is a biotech company that provides personalized therapies to individuals suffering from mental health conditions.
Stephen Kanes: Chief Executive OfficerPast Role: SAGE Therapeutics, Chief Medical Officer
About the Company
EmbarkNeuro is a biotech company that provides personalized therapies to individuals suffering from mental health conditions. It helps people suffering from depression by finding a biomarker associated with the stress response system. Additionally, a new medication called ANC-501 is being developed to treat these patients specifically.